Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
about
Herbal Medicines for Asthmatic Inflammation: From Basic Researches to Clinical ApplicationsReslizumab in the management of poorly controlled asthma: the data so farAssociation of single-nucleotide polymorphisms in toll-like receptor 2 gene with asthma susceptibility: A meta-analysisDeciphering the black box of food allergy mechanisms.Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.Targeted Therapy for Severe Asthma: Identifying the Right Patients.PGI2 Controls Pulmonary NK Cells That Prevent Airway Sensitization to House Dust Mite Allergen.Fungal Ribotoxins: A Review of Potential Biotechnological Applications.Functions of tissue-resident eosinophils.Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma.Strain Differences in a Murine Model of Air Pollutant-induced Nonatopic Asthma and Rhinitis.Pathological and therapeutic roles of innate lymphoid cells in diverse diseases.Progress in the understanding of the pathology of allergic asthma and the potential of fruit proanthocyanidins as modulators of airway inflammation.Type 2 immunity in asthma.Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic ResponsesA purinergic P2Y6 receptor agonist prodrug modulates airway inflammation, remodeling, and hyperreactivity in a mouse model of asthma
P2860
Q26740400-7739B609-253E-4430-B41A-175446D9062EQ28078290-05309EE5-D27E-4293-9563-01EADE7338ABQ33714366-240F9A37-09D7-4C95-B13C-C2CD86951084Q39050465-B32BAAA4-3366-4C51-A4F0-E5FE023E6D0BQ39063083-DA260E4C-B748-4FE2-BCF7-F50761F0DBF1Q39065311-F11DB16C-F234-43D2-A8CC-08632DBF6FB3Q39147430-BE774E41-15AA-4151-8C96-4F367EE8F838Q39147928-30D2A4DC-734E-44B9-8B47-C14DDD92F3A3Q40054108-0D0B07A1-5ACE-4878-9D0E-341BA51BCD97Q41605623-80676F9E-D5D1-431D-80BB-C63DDE7EC762Q46435043-B6573F98-4742-4888-9E7A-33876A479C93Q47897160-54CA74C9-B14C-4130-9DC9-50C03C92F472Q50000630-2C45AB99-94C8-4036-86BC-C08172ADAE50Q55454410-7F6E9FAC-4691-4D21-A3A1-4DC9775A0994Q58572698-2DBC5DA9-4AA7-45B7-AF75-D58E0872CA11Q58806323-CACDBFA5-FC32-4D55-83CA-E9D4C446FCAE
P2860
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@ast
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@en
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@nl
type
label
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@ast
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@en
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@nl
prefLabel
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@ast
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@en
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@nl
P2093
P2860
P921
P3181
P1476
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma
@en
P2093
Helen von Richthofen
Leonie van Rijt
Ronald van Ree
P2860
P2888
P304
P3181
P356
10.1007/S00281-016-0556-2
P407
P577
2016-07-01T00:00:00Z
P5875
P6179
1030926235